MindWalk Holdings Corp.

NASDAQ:HYFT

Biotechnology

Healthcare
$1.08 +0.33%

+$0.01 today

Market cap
$50.88M
Beta
0.82
P/E (TTM)
-8.1
EPS (TTM)
-$0.26
52W Low $0.82High $3.25

Volume 0.20M

Average 0.32M

HYFT Net Income

Bottom-line profit, the starting point for calculating cash from operations.

MindWalk Holdings Corp.NASDAQ: HYFT

Net Income · Q3 FY2026 · quarter ended Jan 2026

Net income declines year over year

Q3 FY2026 net income of CA$3.87M (cash outflow) fell 82.0% year over year, behind the -73.6% change in trailing-twelve-month net income. Sequentially, it rose 21.0% from the prior quarter. Over 3 fiscal years it compounded at +21.9% a year.

Context

  • Net income amounted to 123.3% of revenue in FY2025, up 12.5 pp from a year earlier.
  • Net income grew in size in 3 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 2 analysts of -CA$10.48M (-65.3%) for the fiscal year ending Apr 2026, a slowdown from the +11.2% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJan 2026
-CA$3.87M+21.0% QoQ
Last fiscal yearApr 2025
-CA$30.23M+11.2% YoY
LTMJan 2026
-CA$12.18M-73.6% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-82.0%+15.2%+97.2 pp
1 year+11.2%-65.3%-76.6 pp
3-year CAGR+21.9%-27.1%-48.9 pp
5-year CAGR-26.9%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

CAD · from the cash flow

Latest · FY2025
(30.23M) CAD
Year-over-year change
-11.2%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How HYFT compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -73.6% is the lowest of 9, against a peer median of +27.2%.
  • Net income amounts to 66.4% of revenue for HYFT, versus a peer median of 13601.7%.
HYFT Competitors
Net Income for HYFT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$108M USD+21.2%+44.8%—
FBIOFortress Biotech, Inc.LTM Mar 2026$102.15M USD+215.2%-46.4%154.4%
ALXOALX Oncology Holdings Inc.LTM Mar 2026$88.87M USD-31.7%-6.3%—
CAMPCAMP4 Therapeutics CorporationLTM Mar 2026$86.3M USD+66.7%—2193.7%
ATYRaTyr Pharma, Inc.LTM Mar 2026$70.03M USD+10.4%+17.8%36859.5%
UNCYUnicycive Therapeutics, Inc.LTM Mar 2026$39.95M USD+162.9%+13.7%—
CLNNClene Inc.LTM Mar 2026$33.51M USD+15.3%-4.4%25009.7%
HYFTMindWalk Holdings Corp.LTM Jan 2026CA$12.18M CAD-73.6%+21.9%66.4%
BYSIBeyondSpring Inc.LTM Mar 2026$8.18M USD+33.3%-38.4%—
Peer median (excluding HYFT) —+27.2%-4.4%13601.7%

Competitors are the stored peer set for HYFT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Apr 2021
FY2022
Apr 2022
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
Net Income(7.34M)(16.71M)(26.56M)(27.18M)(30.23M)
Depreciation & Amortization3.71M3.77M6.69M5.74M5.12M
Deferred Income Tax(83K)(336K)(926K)(1.77M)(3.94M)
Stock-Based Compensation2.75M3.08M1.94M1.54M445K
Change in Working Capital(1.02M)582K(3.28M)2.4M276.99K
Accounts Receivables(439K)163K(561K)(241K)(391.8K)
Inventory(316K)(501K)(185K)(102K)99.03K
Accounts Payables(73K)781K(1.55M)994.8K593.45K
Other Working Capital(190K)139K(976K)1.75M(23.68K)
Other Non-Cash Items1.38M(310K)2.3M15.03M21.92M
Operating Cash Flow(600K)(9.92M)(19.83M)(4.25M)(6.41M)
Capital Expenditures(1.43M)(1.26M)(1.5M)(1.4M)(799K)
Acquisitions (Net)(1.03M)(3.69M)(592K)(146K)0
Purchases of Investments00000
Sales of Investments0080K121K0
Other Investing Activities0(259K)40K(141K)0
Investing Cash Flow(2.46M)(5.21M)(1.97M)(1.56M)(799K)
Debt Repayment(772K)(962K)(1.34M)(1.34M)2.67M
Common Stock Issued44.15M3.85M716K1.75M12.23M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities0(5K)0612.26K0
Financing Cash Flow43.38M2.88M(621K)1.02M14.89M
Effect of Forex Changes(1.18M)455K740K(33K)(438K)
Net Change in Cash39.15M(11.79M)(21.68M)(4.82M)7.25M
Free Cash Flow(2.03M)(11.18M)(21.33M)(5.64M)(7.21M)

MindWalk Holdings Corp.

NASDAQ:HYFT

Intrinsic Alpha fair value

Locked

Current Price

$1.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.